Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? - Suppr | 超能文献

Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?

作者信息

Speer C P, Robertson B, Halliday H L

机构信息

Department of Pediatrics, University Children 's Hospital, Wuerburg, Germany.

出版信息

Acta Paediatr. 2000 May;89(5):510-2. doi: 10.1080/080352500750027754.

DOI:10.1080/080352500750027754

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?

Acta Paediatr. 2000 May;89(5):510-2. doi: 10.1080/080352500750027754.

2

[Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].[天然或合成表面活性剂治疗新生儿呼吸窘迫综合征]

Tidsskr Nor Laegeforen. 1994 Feb 20;114(5):590-1.

3

Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?比较天然表面活性剂和合成表面活性剂的随机试验：使用天然表面活性剂后感染率会增加吗？

Acta Paediatr. 2000 May;89(5):556-61. doi: 10.1080/080352500750027853.

4

Changes in pulmonary artery pressure in infants with respiratory distress syndrome after treatment with Exosurf.使用埃索苏尔夫治疗后呼吸窘迫综合征婴儿的肺动脉压力变化

Arch Dis Child Fetal Neonatal Ed. 1996 Mar;74(2):F151. doi: 10.1136/fn.74.2.f151-a.

5

Comparison of clinical responses to natural and synthetic surfactants.天然表面活性剂与合成表面活性剂临床反应的比较。

J Perinat Med. 1993;21(5):341-7. doi: 10.1515/jpme.1993.21.5.341.

6

Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials.合成表面活性剂：我们处于什么阶段？来自随机对照临床试验的证据。

J Perinatol. 2009 May;29 Suppl 2:S23-8. doi: 10.1038/jp.2009.26.

7

Overview of clinical trials comparing natural and synthetic surfactants.

Biol Neonate. 1995;67 Suppl 1:32-47. doi: 10.1159/000244205.

8

Comparing surfactant products.比较表面活性剂产品。

Clin Pharm. 1991 Dec;10(12):909, 911.

9

Double-blind, randomized, placebo-controlled Canadian multicenter trial of two doses of synthetic surfactant or air placebo in 224 infants weighing 500 to 749 grams with respiratory distress syndrome. Canadian Exosurf Neonatal Study Group.加拿大多中心双盲、随机、安慰剂对照试验：对224名体重500至749克患有呼吸窘迫综合征的婴儿使用两剂合成表面活性剂或空气安慰剂。加拿大Exosurf新生儿研究组。

J Pediatr. 1995 May;126(5 Pt 2):S81-9. doi: 10.1016/s0022-3476(95)70012-9.

10

Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.新生儿呼吸窘迫综合征的单剂量表面活性剂挽救治疗

Indian Pediatr. 1998 Jun;35(6):533-6.

引用本文的文献

1

Poractant alfa (Curosurf®) increases phagocytosis of apoptotic neutrophils by alveolar macrophages in vivo.肺表面活性物质蛋白 Alfa（固尔苏®）增加肺泡巨噬细胞对凋亡中性粒细胞的吞噬作用。

Respir Res. 2012 Mar 9;13(1):17. doi: 10.1186/1465-9921-13-17.